{
    "2019-10-23": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Is a Beat in Store for Glaxo (GSK) This Earnings Season?",
                "features": {
                    "keywords": [
                        "earnings season",
                        "beat",
                        "Glaxo"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Novartis shells out $80M for Peninsula company's preclinical liver drug",
                "features": {
                    "keywords": [
                        "Novartis",
                        "acquisition",
                        "preclinical",
                        "liver drug"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Will Strong Jakafi Sales Drive Incyte's (INCY) Q3 Earnings?",
                "features": {
                    "keywords": [
                        "Jakafi sales",
                        "Incyte",
                        "Q3 earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Big Biotech Receives Some Needed Shots in the Arm",
                "features": {
                    "keywords": [
                        "big biotech",
                        "needed shots",
                        "support"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}